We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
-29.15%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.2M
AUM Growth
-$9.87M
Cap. Flow
+$310K
Cap. Flow %
1.28%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

1
AZTA icon
Azenta
AZTA
+$4.86M

Top Sells

1
CRL icon
Charles River Laboratories
CRL
+$3.24M
2
CTLT
CATALENT, INC.
CTLT
+$1.31M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZTA icon
1
Azenta
AZTA
$1.23B
$10.5M 43.22%
244,501
+81,325
+50% +$4.86M
CTLT
2
DELISTED
CATALENT, INC.
CTLT
$6.98M 28.81%
96,528
-13,156
-12% -$1.31M
CRL icon
3
Charles River Laboratories
CRL
$11B
$6.78M 27.97%
34,459
-15,011
-30% -$3.24M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Tower House Partners held 3 positions worth $24.2M, down 29% from $34.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Tower House Partners opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tower House Partners added most to Azenta in Q3 2022, an estimated $4.86M increase.
  • Tower House Partners's biggest Q3 2022 reduction was Charles River Laboratories, cutting an estimated $3.24M.
  • Tower House Partners's ten largest holdings make up 100% of its $24.2M portfolio in Q3 2022.
  • Tower House Partners opened 0 new positions and closed 0 in Q3 2022.
  • Tower House Partners's portfolio value fell 29% quarter-over-quarter to $24.2M.

Based on Tower House Partners's 13F filing for Q3 2022, filed 14 Nov 2022.